Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'lauric acid'

Search results for: 'lauric acid'

Items 291-300 of 797

Page
per page
  1. NMDA (N-Methyl-D-aspartic acid)
    B1624 NMDA (N-Methyl-D-aspartic acid)
    Summary: NMDA receptor agonist
      insoluble in EtOH; ≥39.07 mg/mL
  2. 3-hydroxy Anthranilic Acid
    C5792 3-hydroxy Anthranilic Acid
    Summary: co-antioxidant
      insoluble in H2O; insoluble in EtOH; ≥24.05 mg/mL
  3. Adrenorphin, Free Acid
    A1017 Adrenorphin, Free Acid
    Summary: μ/κ opioid receptor agonist
      ≥27.75 mg/mL
  4. 2,3-Diaminopropionic acid hydrochloride
    C6585 2,3-Diaminopropionic acid hydrochloride
      Insoluble in DMSO; insoluble in EtOH; ≥27.4 mg/mL
  5. 2-hydroxymethyl benzoic acid
    C6664 2-hydroxymethyl benzoic acid
      ≥30.5 mg/mL
  6. Oxalic acid dihydrate
    C6911 Oxalic acid dihydrate
      ≥20.6 mg/mL
  7. Nicotinic acid N-oxide
    C7149 Nicotinic acid N-oxide
      ≥7.67 mg/mL
  8. Cholic acid sodium
    C7191 Cholic acid sodium
      ≥56.1 mg/mL
  9. ENMD-2076 L-(+)-Tartaric acid
    A4129 ENMD-2076 L-(+)-Tartaric acid
    Summary: Aurora kinases inhibitor
      insoluble in EtOH; ≥175.8 mg/mL
  10. WY-14643 (Pirinixic Acid)
    A4305 WY-14643 (Pirinixic Acid)
     1 Citation
    Target: PPAR
    Summary: PPARα agonist,selective and highly potent
      insoluble in H2O; ≥16.2 mg/mL

Items 291-300 of 797

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways297item
  2. Natural Products68item
  3. Other Products2item
  4. Protein2item
  5. Kits7item
  6. Screening Library13item
  7. Modified Nucleotides2item
  8. Peptides3item
  9. Molecular Biology16item
  10. Probes & Dyes13item
  11. Cell Biology9item
  12. Peptides & Proteins14item
  13. Protein & Immunology8item
  14. Lab Reagents6item
  15. Others16item
  16. Antibody11item
  17. mRNA/In Vitro Transcription3item
  18. Enzymes2item
  19. Biochemical Reagent251item
  20. Protein Biology1 item
Specificity
  1. Selective22item
Reversibility
  1. Irreversible1 item
Target
  1. Histone Deacetylases (HDACs)4item
  2. Farnesoid X receptors (FXRs)2item
  3. LPA Receptors2item
  4. p381 item
  5. Neuraminidases (NA)1 item
  6. RARs2item
  7. Aminopeptidases1 item
  8. Topoisomerases1 item
  9. Calcium ionophores1 item
  10. Farnesyl Diphosphate Synthases1 item
  11. RAR/RXR1 item
  12. Monoamine oxidases (MAOs)1 item
  13. TRP Channel1 item
  14. fibrinolysis1 item
  15. Antioxidants1 item
  16. GPR401 item
  17. KDM1 item
  18. PPAR1 item
  19. GABA receptors1 item
  20. Vitamin D receptors (VDRs)1 item
  21. EAA receptor1 item
  22. HIV1 item
  23. Histone Acetyltransferases (HATs)1 item
  24. Pregnane X receptor(PXR)1 item
  25. FAAH1 item
  26. PHF1 item
  27. HMG1 item
  28. HSD1 item
Reported Experiments
  1. Animal Experiments28item
  2. Cell Experiments26item
Related Disease
  1. Acute Myelogenous Leukemia1 item
  2. Bladder Cancer1 item
  3. Brain Injuries Studies1 item
  4. Breast Cancer2item
  5. Cancer9item
  6. Colon Cancer2item
  7. Colorectal Cancer1 item
  8. Epilepsy1 item
  9. Glioblastoma1 item
  10. HIV Infections1 item
  11. Inflammation1 item
  12. Inflammatory Diseases1 item
  13. Influenza1 item
  14. Lymphoma1 item
  15. Melanoma1 item
  16. Non-small Cell Lung Cancer1 item
  17. Pain Relief1 item
  18. Pancreatic Cancer4item
  19. Pentacyclic Triterpenoid1 item
  20. Prostate Cancer1 item
  21. Type 2 Diabetes1 item